Lieneck, CristianMcLauchlan, MatthewAdachi, ValerieBillings, Roger2024-04-042024-04-042024-03Lieneck, C., McLauchlan, M., Adachi, V., & Billings, R. (2024). Stakeholder perspectives of the Inflation Reduction Act’s (2022) impact on prescription drugs. Poster presented at the Health Scholar Showcase, Translational Health Research Center, San Marcos, Texas.https://hdl.handle.net/10877/18397IN this review, we examine the impact of the Inflation Reduction Act (IRA) of 2022 on pharmaceutical drugs in the United States, drawing on a diverse range of sources to understand the perceptions of multiple stakeholders and professionals. Findings suggest that the Act, while aiming to control price inflation, has had a multifaceted impact on the pharmaceutical sector.Image1 page1 file (.pdf)enInflation Reduction Actprescription drugsPoster